June 6, 2025
June 9, 2025
This week’s newsletter included:
- Recap of Australia Clinical Trials Event
- Rep. Kennedy Highlights Utah’s Life Sciences Industry at Committee Hearing
- Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for MDS
- VETFIRE: bioMerieux Launches Cutting-edge Equine Infectious Respiratory Disease Testing
- Arcutis’ ZORYVE (roflumilast) Topical Foam 0.3% Approved by FDA
- Renalytix Growing Collaboration with New York Kidney & Hypertension Medicine
- CancerVax Launches New StartEngine Fundraising Campaign
- CanverVax’s New Chief Scientific Officer, Dr. George Katibah
- CancerVax Scientists Featured on Cytiva’s Discovery Matters Podcast Discussing Universal Cancer Vaccine Platform
- Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
- Don’t Miss BioUtah’s Exclusive Biosphere Magazine Promotional Opportunity
- University of Utah Founders Day Distinguished Alumni Awards
- Utah Business: Nominations for Innovation Awards Open
Featured New BioUtah Elite Bronze Member: AstraZeneca
Recent News
- Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence
- Seek Labs Unveils BioSeeker™
- Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
- Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer
- Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease
- Improving Women’s Health: MobileODT Joins Liger Medical
